Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Primary Language on Treatment and Outcomes in Inflammatory Bowel Disease

NCT06405503 is registered in ClinicalTrials.gov with University of Texas at Austin as lead sponsor.

NCT NCT06405503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06405503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Primary Language on Treatment and Outcomes in Inflammatory Bowel Disease
Lead sponsor
University of Texas at Austin
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2024
Completion date
June 30, 2025
Enrollment
206 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease